ADSS expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.39153141734505E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.45612468935997E-12 |
Normal-vs-Stage2 |
3.0181000032492E-08 |
Normal-vs-Stage3 |
1.67055258515347E-12 |
Normal-vs-Stage4 |
1.24279475599565E-11 |
Stage1-vs-Stage2 |
7.193000E-01 |
Stage1-vs-Stage3 |
2.210000E-02 |
Stage1-vs-Stage4 |
2.618600E-01 |
Stage2-vs-Stage3 |
7.230400E-02 |
Stage2-vs-Stage4 |
2.802800E-01 |
Stage3-vs-Stage4 |
7.036400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.14550599508812E-12 |
Normal-vs-AfricanAmerican |
2.44140041516516E-10 |
Normal-vs-Asian |
1.217390E-01 |
Caucasian-vs-AfricanAmerican |
4.812600E-01 |
Caucasian-vs-Asian |
6.512300E-02 |
AfricanAmerican-vs-Asian |
8.387600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.12194714524594E-13 |
Normal-vs-Female |
1.88999926820088E-11 |
Male-vs-Female |
2.634000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.92420000000304E-06 |
Normal-vs-Age(41-60Yrs) |
7.34690086545697E-12 |
Normal-vs-Age(61-80Yrs) |
1.97786231836972E-12 |
Normal-vs-Age(81-100Yrs) |
9.09340380772505E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.039600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.637800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.415160E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.619400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.391980E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.665000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.0040000000059E-05 |
Normal-vs-Grade 2 |
2.77710077156712E-11 |
Normal-vs-Grade 3 |
1.96065386148803E-13 |
Normal-vs-Grade 4 |
1.70996550252767E-12 |
Grade 1-vs-Grade 2 |
5.769600E-01 |
Grade 1-vs-Grade 3 |
1.908570E-01 |
Grade 1-vs-Grade 4 |
7.669800E-02 |
Grade 2-vs-Grade 3 |
6.315500E-02 |
Grade 2-vs-Grade 4 |
3.329600E-02 |
Grade 3-vs-Grade 4 |
3.923800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.25184365282894E-12 |
Normal-vs-ccB subtype |
2.14483986127334E-12 |
ccA subtype-vs-ccB subtype |
5.613800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.03859151781671E-12 |
Normal-vs-N1 |
9.591100E-04 |
N0-vs-N1 |
3.993400E-01 |
|
|